Pfizer is axing its neurosciences division, laying off 300 and discarding new drugs

Pfizer is starting out 2018 by ripping up its early-, mid-stage and preclinical R&D operations focused on neurosciences and laying off hundreds of workers engaged in the development work. In a statement, Pfizer $PFE says it is is axing about 300 workers in Connecticut and Massachusetts — about 100 each in Andover, Groton and Cambridge, where … Continue reading Pfizer is axing its neurosciences division, laying off 300 and discarding new drugs